ONTOLOGY REPORT - ANNOTATIONS
| Term: | lithium atom |
|
| Accession: | CHEBI:30145
|
browse the term
|
| Definition: | An alkali metal atom that has formula Li. |
| Synonyms: | related_synonym: | 3Li; InChI=1S/Li; InChIKey=WHXSMMKQMYFTQS-UHFFFAOYSA-N; Li; lithium; litio |
| | xref_casrn: | 7439-93-2 |
| | xref_mesh: | MESH:D008094 |
| | xref: | NIST Chemistry WebBook:7439-93-2 "CAS Registry Number"; WebElements:Li "WebElements" |
|
|
lithium atom
|
| G |
Aanat |
arylalkylamine N-acetyltransferase |
|
multiple interactions |
ISO |
11 |
116,455,001 |
116,458,994 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, sub-family B (MDR/TAP), member 1B |
|
increases expression |
ISO |
5 |
8,798,147 |
8,866,314 |
RGD:6480464 |
CTD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
multiple interactions |
ISO |
19 |
55,327,859 |
55,371,118 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
increases expression |
ISO |
5 |
143,664,795 |
143,668,403 |
RGD:6480464 |
CTD |
| G |
Actr3 |
ARP3 actin-related protein 3 |
|
increases expression |
ISO |
1 |
127,289,483 |
127,332,067 |
RGD:6480464 |
CTD |
| G |
Adk |
adenosine kinase |
|
increases expression |
ISO |
14 |
21,871,855 |
22,267,769 |
RGD:6480464 |
CTD |
| G |
Adnp2 |
ADNP homeobox 2 |
|
increases expression |
ISO |
18 |
80,323,874 |
80,348,221 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
increases expression |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
increases phosphorylation |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase family 1, subfamily A3 |
|
decreases expression |
ISO |
7 |
73,535,778 |
73,572,363 |
RGD:6480464 |
CTD |
| G |
Antxr2 |
anthrax toxin receptor 2 |
|
increases expression |
ISO |
5 |
98,313,707 |
98,459,981 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
decreases expression |
ISO |
9 |
69,301,490 |
69,339,592 |
RGD:6480464 |
CTD |
| G |
Anxa4 |
annexin A4 |
|
increases expression |
ISO |
6 |
86,686,834 |
86,743,578 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
increases expression |
ISO |
3 |
36,347,845 |
36,374,809 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
EXP |
16 |
84,954,688 |
85,173,948 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
16 |
84,954,688 |
85,173,948 |
RGD:6480464 |
CTD |
| G |
Aprt |
adenine phosphoribosyl transferase |
|
increases expression |
ISO |
8 |
125,098,537 |
125,100,807 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
multiple interactions |
EXP |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
multiple interactions |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
multiple interactions |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
decreases expression |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
decreases expression |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
increases expression |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
decreases expression |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
decreases expression |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
decreases expression |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
decreases expression |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
decreases expression |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
decreases expression |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
decreases expression |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
decreases expression |
ISO |
4 |
41,039,757 |
41,045,216 |
RGD:6480464 |
CTD |
| G |
Aqp6 |
aquaporin 6 |
|
increases expression |
ISO |
15 |
99,431,831 |
99,435,908 |
RGD:6480464 |
CTD |
| G |
Arg2 |
arginase type II |
|
multiple interactions |
ISO |
12 |
80,231,775 |
80,257,288 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
multiple interactions |
ISO |
2 |
73,654,578 |
73,730,685 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated homolog (human) |
|
decreases expression |
ISO |
9 |
53,245,227 |
53,344,776 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
multiple interactions |
ISO |
3 |
101,380,146 |
101,408,580 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
decreases expression |
ISO |
3 |
101,380,146 |
101,408,580 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
increases expression |
ISO |
3 |
101,380,146 |
101,408,580 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
multiple interactions |
ISO |
1 |
174,201,840 |
174,228,195 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
ISO |
5 |
122,903,522 |
122,952,234 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit |
|
increases expression |
ISO |
10 |
127,520,363 |
127,527,444 |
RGD:6480464 |
CTD |
| G |
Atp5d |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
|
increases expression |
ISO |
10 |
79,605,060 |
79,608,563 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases expression |
ISO |
2 |
130,406,413 |
130,408,277 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
ISO |
2 |
130,406,413 |
130,408,277 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
affects expression |
ISO |
2 |
130,406,413 |
130,408,277 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene 1 |
|
increases expression |
ISO |
4 |
40,883,431 |
40,895,327 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
decreases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
affects response to substance |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
increases response to substance |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
multiple interactions |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
multiple interactions |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
multiple interactions |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
increases expression |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
increases expression |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
decreases expression |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Bub1b |
budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) |
|
increases expression |
ISO |
2 |
118,423,947 |
118,467,328 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
increases expression |
ISO |
8 |
87,365,987 |
87,370,830 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
increases expression |
ISO |
18 |
33,098,695 |
33,355,421 |
RGD:6480464 |
CTD |
| G |
Camkk2 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
|
increases expression |
ISO |
5 |
123,183,197 |
123,214,303 |
RGD:6480464 |
CTD |
| G |
Car2 |
carbonic anhydrase 2 |
|
increases expression |
ISO |
3 |
14,886,426 |
14,900,770 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
multiple interactions |
ISO |
9 |
5,345,476 |
5,373,034 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
9 |
5,308,860 |
5,336,791 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
19 |
56,471,619 |
56,516,834 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
multiple interactions |
ISO |
3 |
54,849,391 |
54,858,977 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
ISO |
9 |
70,255,496 |
70,269,361 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
multiple interactions |
ISO |
6 |
127,075,726 |
127,101,066 |
RGD:6480464 |
CTD |
| G |
Cd151 |
CD151 antigen |
|
decreases expression |
ISO |
7 |
148,653,261 |
148,657,380 |
RGD:6480464 |
CTD |
| G |
Cdca3 |
cell division cycle associated 3 |
|
increases expression |
ISO |
6 |
124,780,194 |
124,783,719 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
EXP |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
increases expression |
ISO |
19 |
5,490,455 |
5,494,031 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
ISO |
12 |
112,907,566 |
112,910,549 |
RGD:6480464 |
CTD |
| G |
Cox5a |
cytochrome c oxidase subunit Va |
|
increases expression |
ISO |
9 |
57,369,039 |
57,380,234 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
increases expression |
ISO |
1 |
36,748,332 |
36,750,233 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
increases expression |
ISO |
1 |
36,748,332 |
36,750,233 |
RGD:6480464 |
CTD |
| G |
Crip1 |
cysteine-rich protein 1 (intestinal) |
|
increases expression |
ISO |
12 |
114,390,223 |
114,392,090 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
decreases expression |
ISO |
9 |
50,560,863 |
50,564,738 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
EXP |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
affects localization |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases expression |
ISO |
7 |
149,561,821 |
149,573,775 |
RGD:6480464 |
CTD |
| G |
Ddr2 |
discoidin domain receptor family, member 2 |
|
decreases expression |
ISO |
1 |
171,902,438 |
172,019,075 |
RGD:6480464 |
CTD |
| G |
Ddx21 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 |
|
multiple interactions |
ISO |
10 |
62,042,995 |
62,065,046 |
RGD:6480464 |
CTD |
| G |
Drd1a |
dopamine receptor D1A |
|
affects response to substance |
ISO |
13 |
54,146,552 |
54,151,027 |
RGD:6480464 |
CTD |
| G |
Drd1a |
dopamine receptor D1A |
|
increases response to substance |
ISO |
13 |
54,146,552 |
54,151,027 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
decreases expression |
ISO |
9 |
49,148,767 |
49,215,319 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
17 |
26,642,536 |
26,645,417 |
RGD:6480464 |
CTD |
| G |
Dynlrb1 |
dynein light chain roadblock-type 1 |
|
increases expression |
ISO |
2 |
155,062,269 |
155,076,013 |
RGD:6480464 |
CTD |
| G |
Ech1 |
enoyl coenzyme A hydratase 1, peroxisomal |
|
increases expression |
ISO |
7 |
29,610,357 |
29,617,258 |
RGD:6480464 |
CTD |
| G |
Ect2 |
ect2 oncogene |
|
increases expression |
ISO |
3 |
26,996,144 |
27,052,800 |
RGD:6480464 |
CTD |
| G |
Ect2 |
ect2 oncogene |
|
increases expression |
ISO |
3 |
26,996,144 |
27,052,800 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
increases expression |
ISO |
9 |
78,326,260 |
78,329,531 |
RGD:6480464 |
CTD |
| G |
Eif3k |
eukaryotic translation initiation factor 3, subunit K |
|
increases expression |
ISO |
7 |
29,756,392 |
29,766,833 |
RGD:6480464 |
CTD |
| G |
Etfb |
electron transferring flavoprotein, beta polypeptide |
|
increases expression |
ISO |
7 |
50,699,513 |
50,713,152 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
increases expression |
ISO |
17 |
6,942,480 |
6,987,129 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
increases expression |
ISO |
17 |
6,942,480 |
6,987,129 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
increases expression |
ISO |
17 |
6,942,480 |
6,987,129 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
multiple interactions |
ISO |
19 |
34,365,149 |
34,402,260 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fosb |
FBJ osteosarcoma oncogene B |
|
increases expression |
ISO |
7 |
19,888,045 |
19,895,394 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone beta |
|
multiple interactions |
ISO |
2 |
106,896,297 |
106,899,808 |
RGD:6480464 |
CTD |
| G |
Ftl1 |
ferritin light chain 1 |
|
increases expression |
ISO |
7 |
52,713,314 |
52,715,256 |
RGD:6480464 |
CTD |
| G |
Gabpa |
GA repeat binding protein, alpha |
|
multiple interactions |
ISO |
16 |
84,835,369 |
84,864,024 |
RGD:6480464 |
CTD |
| G |
Galm |
galactose mutarotase |
|
decreases expression |
ISO |
17 |
80,526,811 |
80,584,372 |
RGD:6480464 |
CTD |
| G |
Ganab |
alpha glucosidase 2 alpha neutral subunit |
|
increases expression |
ISO |
19 |
8,972,601 |
8,991,156 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell line derived neurotrophic factor |
|
multiple interactions |
ISO |
15 |
7,761,011 |
7,787,575 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
ISO |
10 |
56,097,106 |
56,110,225 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
multiple interactions |
ISO |
1 |
52,220,293 |
52,290,076 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamate oxaloacetate transaminase 2, mitochondrial |
|
multiple interactions |
ISO |
8 |
98,388,037 |
98,412,265 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamate oxaloacetate transaminase 2, mitochondrial |
|
decreases expression |
ISO |
8 |
98,388,037 |
98,412,265 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic pyruvic transaminase, soluble |
|
multiple interactions |
ISO |
15 |
76,527,194 |
76,530,105 |
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
|
decreases expression |
ISO |
11 |
56,825,193 |
57,143,746 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
|
multiple interactions |
ISO |
3 |
80,488,858 |
80,606,713 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
|
decreases expression |
ISO |
3 |
80,488,858 |
80,606,713 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
|
multiple interactions |
ISO |
X |
38,754,481 |
39,031,778 |
RGD:6480464 |
CTD |
| G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
|
decreases expression |
EXP |
10 |
48,819,269 |
49,508,560 |
RGD:6480464 |
CTD |
| G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
|
multiple interactions |
ISO |
10 |
48,819,269 |
49,508,560 |
RGD:6480464 |
CTD |
| G |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
|
multiple interactions |
ISO |
7 |
25,794,868 |
25,857,388 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
|
multiple interactions |
ISO |
16 |
9,577,803 |
9,992,626 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
|
multiple interactions |
ISO |
6 |
135,679,813 |
136,123,529 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
increases expression |
ISO |
7 |
26,013,278 |
26,022,870 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
multiple interactions |
ISO |
7 |
26,013,278 |
26,022,870 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases expression |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases expression |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases expression |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase, alpha 3 |
|
multiple interactions |
ISO |
1 |
21,230,670 |
21,255,640 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase, alpha 4 |
|
increases expression |
ISO |
9 |
78,039,773 |
78,057,156 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase, mu 1 |
|
increases expression |
ISO |
3 |
107,815,168 |
107,820,891 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase, mu 1 |
|
increases expression |
ISO |
3 |
107,815,168 |
107,820,891 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase, mu 3 |
|
increases expression |
ISO |
3 |
107,766,614 |
107,772,076 |
RGD:6480464 |
CTD |
| G |
Hhex |
hematopoietically expressed homeobox |
|
multiple interactions |
EXP |
19 |
37,509,331 |
37,515,221 |
RGD:6480464 |
CTD |
| G |
Hhex |
hematopoietically expressed homeobox |
|
affects expression |
EXP |
19 |
37,509,331 |
37,515,221 |
RGD:6480464 |
CTD |
| G |
Hilpda |
hypoxia inducible lipid droplet associated |
|
decreases expression |
ISO |
6 |
29,222,488 |
29,225,449 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Homer3 |
homer homolog 3 (Drosophila) |
|
decreases expression |
ISO |
8 |
72,806,898 |
72,818,260 |
RGD:6480464 |
CTD |
| G |
Hprt |
hypoxanthine guanine phosphoribosyl transferase |
|
increases expression |
ISO |
X |
50,341,255 |
50,374,837 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
increases expression |
ISO |
8 |
108,042,646 |
108,047,888 |
RGD:6480464 |
CTD |
| G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
|
increases expression |
ISO |
X |
148,436,439 |
148,438,985 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
|
increases expression |
ISO |
10 |
86,153,586 |
86,168,189 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
|
increases expression |
ISO |
10 |
86,153,586 |
86,168,189 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
|
increases expression |
ISO |
10 |
86,153,586 |
86,168,189 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
ISO |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa1l |
heat shock protein 1-like |
|
decreases expression |
ISO |
17 |
35,109,648 |
35,116,173 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
2 |
34,627,610 |
34,632,049 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
multiple interactions |
ISO |
18 |
35,097,068 |
35,114,005 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases expression |
ISO |
18 |
35,097,068 |
35,114,005 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12b |
|
multiple interactions |
EXP |
11 |
44,213,565 |
44,227,519 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
EXP |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
increases expression |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
increases secretion |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Impa1 |
inositol (myo)-1(or 4)-monophosphatase 1 |
|
decreases response to substance |
EXP |
3 |
10,313,540 |
10,331,439 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Junb |
Jun-B oncogene |
|
multiple interactions |
ISO |
8 |
87,500,811 |
87,502,617 |
RGD:6480464 |
CTD |
| G |
Kif20a |
kinesin family member 20A |
|
increases expression |
ISO |
18 |
34,784,278 |
34,792,931 |
RGD:6480464 |
CTD |
| G |
Kif23 |
kinesin family member 23 |
|
increases expression |
ISO |
9 |
61,765,084 |
61,794,606 |
RGD:6480464 |
CTD |
| G |
Kifc1 |
kinesin family member C1 |
|
increases expression |
ISO |
17 |
34,012,611 |
34,027,600 |
RGD:6480464 |
CTD |
| G |
Kifc1 |
kinesin family member C1 |
|
increases expression |
ISO |
17 |
34,012,611 |
34,027,600 |
RGD:6480464 |
CTD |
| G |
Klf6 |
Kruppel-like factor 6 |
|
affects expression |
ISO |
13 |
5,860,735 |
5,869,639 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lmna |
lamin A |
|
increases expression |
ISO |
3 |
88,285,071 |
88,307,254 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
EXP |
9 |
64,033,600 |
64,101,412 |
RGD:6480464 |
CTD |
| G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
increases degradation |
EXP |
18 |
4,331,325 |
4,352,951 |
RGD:6480464 |
CTD |
| G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
multiple interactions |
EXP |
18 |
4,331,325 |
4,352,951 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases activity |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases expression |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases activity |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases expression |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases expression |
ISO |
11 |
49,660,253 |
49,699,923 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
ISO |
11 |
104,092,750 |
104,193,410 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
|
increases expression |
ISO |
7 |
142,881,471 |
142,908,062 |
RGD:6480464 |
CTD |
| G |
Mrpl18 |
mitochondrial ribosomal protein L18 |
|
multiple interactions |
ISO |
17 |
13,104,221 |
13,108,957 |
RGD:6480464 |
CTD |
| G |
Mrpl53 |
mitochondrial ribosomal protein L53 |
|
multiple interactions |
ISO |
6 |
83,059,102 |
83,059,926 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
EXP |
4 |
147,822,691 |
147,931,794 |
RGD:6480464 |
CTD |
| G |
Myl6 |
myosin, light polypeptide 6, alkali, smooth muscle and non-muscle |
|
decreases expression |
ISO |
10 |
127,927,917 |
127,930,881 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases activity |
EXP |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
multiple interactions |
EXP |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
increases degradation |
EXP |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
increases expression |
ISO |
11 |
93,811,129 |
93,817,321 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
ISO |
5 |
118,317,128 |
118,403,822 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
5 |
118,317,128 |
118,403,822 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
ISO |
6 |
49,772,728 |
49,779,506 |
RGD:6480464 |
CTD |
| G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
affects response to substance |
ISO |
11 |
98,629,249 |
98,636,556 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
EXP |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
increases expression |
ISO |
2 |
56,959,637 |
56,976,414 |
RGD:6480464 |
CTD |
| G |
Nsfl1c |
NSFL1 (p97) cofactor (p47) |
|
increases expression |
ISO |
2 |
151,320,044 |
151,337,041 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
multiple interactions |
ISO |
6 |
126,051,430 |
126,116,762 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
increases expression |
ISO |
6 |
126,051,430 |
126,116,762 |
RGD:6480464 |
CTD |
| G |
Nudt4 |
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
|
increases expression |
ISO |
10 |
95,009,641 |
95,026,801 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
|
decreases expression |
EXP |
6 |
113,276,970 |
113,284,182 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin |
|
increases expression |
ISO |
2 |
130,401,909 |
130,402,724 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin |
|
increases secretion |
ISO |
2 |
130,401,909 |
130,402,724 |
RGD:6480464 |
CTD |
| G |
P2ry4 |
pyrimidinergic receptor P2Y, G-protein coupled, 4 |
|
increases expression |
ISO |
X |
97,785,493 |
97,790,208 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
multiple interactions |
ISO |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp4 |
poly (ADP-ribose) polymerase family, member 4 |
|
increases expression |
ISO |
14 |
57,194,456 |
57,278,635 |
RGD:6480464 |
CTD |
| G |
Pcmt1 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 |
|
increases expression |
ISO |
10 |
7,350,034 |
7,383,382 |
RGD:6480464 |
CTD |
| G |
Pdcd6 |
programmed cell death 6 |
|
increases expression |
ISO |
13 |
74,440,569 |
74,454,774 |
RGD:6480464 |
CTD |
| G |
Pde4a |
phosphodiesterase 4A, cAMP specific |
|
decreases expression |
ISO |
9 |
20,970,158 |
21,017,692 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
decreases expression |
ISO |
4 |
101,927,347 |
102,279,867 |
RGD:6480464 |
CTD |
| G |
Pde8b |
phosphodiesterase 8B |
|
decreases expression |
ISO |
13 |
95,794,060 |
96,020,259 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase associated 3 |
|
increases expression |
ISO |
2 |
121,239,638 |
121,264,423 |
RGD:6480464 |
CTD |
| G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
|
increases expression |
ISO |
5 |
117,732,660 |
117,737,573 |
RGD:6480464 |
CTD |
| G |
Pex1 |
peroxisomal biogenesis factor 1 |
|
increases expression |
ISO |
5 |
3,596,066 |
3,637,101 |
RGD:6480464 |
CTD |
| G |
Pgam1 |
phosphoglycerate mutase 1 |
|
increases expression |
ISO |
19 |
41,986,361 |
41,993,155 |
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
increases expression |
ISO |
11 |
95,528,271 |
95,542,087 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases expression |
EXP |
1 |
151,676,752 |
151,808,414 |
RGD:6480464 |
CTD |
| G |
Pls3 |
plastin 3 (T-isoform) |
|
increases expression |
ISO |
X |
73,030,993 |
73,120,509 |
RGD:6480464 |
CTD |
| G |
Ppia |
peptidylprolyl isomerase A |
|
increases expression |
ISO |
11 |
6,315,873 |
6,319,813 |
RGD:6480464 |
CTD |
| G |
Prdx5 |
peroxiredoxin 5 |
|
increases expression |
ISO |
19 |
6,981,309 |
6,984,135 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
multiple interactions |
ISO |
17 |
86,567,125 |
87,057,259 |
RGD:6480464 |
CTD |
| G |
Prkcg |
protein kinase C, gamma |
|
multiple interactions |
ISO |
7 |
3,303,658 |
3,331,005 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
ISO |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Psmb1 |
proteasome (prosome, macropain) subunit, beta type 1 |
|
increases expression |
ISO |
17 |
15,612,685 |
15,635,240 |
RGD:6480464 |
CTD |
| G |
Psmb9 |
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) |
|
increases expression |
ISO |
17 |
34,319,044 |
34,324,275 |
RGD:6480464 |
CTD |
| G |
Psmd1 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 |
|
decreases expression |
ISO |
1 |
87,961,194 |
88,035,870 |
RGD:6480464 |
CTD |
| G |
Psmd13 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 |
|
increases expression |
ISO |
7 |
148,068,293 |
148,084,541 |
RGD:6480464 |
CTD |
| G |
Psmd8 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
|
increases expression |
ISO |
7 |
29,959,206 |
29,965,692 |
RGD:6480464 |
CTD |
| G |
Psme2 |
proteasome (prosome, macropain) 28 subunit, beta |
|
increases expression |
ISO |
14 |
56,206,277 |
56,209,938 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
7 |
120,529,090 |
120,532,087 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
7 |
120,529,090 |
120,532,087 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
7 |
120,529,090 |
120,532,087 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
7 |
120,529,090 |
120,532,087 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
7 |
120,529,090 |
120,532,087 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
|
multiple interactions |
ISO |
14 |
66,772,094 |
66,899,889 |
RGD:6480464 |
CTD |
| G |
Qars |
glutaminyl-tRNA synthetase |
|
multiple interactions |
ISO |
9 |
108,410,336 |
108,418,272 |
RGD:6480464 |
CTD |
| G |
Racgap1 |
Rac GTPase-activating protein 1 |
|
increases expression |
ISO |
15 |
99,450,927 |
99,482,052 |
RGD:6480464 |
CTD |
| G |
Rad18 |
RAD18 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
6 |
112,569,845 |
112,646,664 |
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
increases expression |
ISO |
5 |
129,526,031 |
129,530,196 |
RGD:6480464 |
CTD |
| G |
Rel |
reticuloendotheliosis oncogene |
|
multiple interactions |
EXP |
11 |
23,641,729 |
23,670,970 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases activity |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
ISO |
5 |
21,390,272 |
21,850,523 |
RGD:6480464 |
CTD |
| G |
Ret |
ret proto-oncogene |
|
multiple interactions |
ISO |
6 |
118,101,766 |
118,147,762 |
RGD:6480464 |
CTD |
| G |
Rgcc |
regulator of cell cycle |
|
increases expression |
ISO |
14 |
79,688,557 |
79,701,442 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
increases expression |
ISO |
1 |
145,846,468 |
145,851,279 |
RGD:6480464 |
CTD |
| G |
Rnmt |
RNA (guanine-7-) methyltransferase |
|
increases expression |
ISO |
18 |
68,460,009 |
68,484,506 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium binding protein A4 |
|
decreases expression |
ISO |
3 |
90,407,692 |
90,409,967 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 (calcyclin) |
|
decreases expression |
ISO |
3 |
90,416,816 |
90,418,336 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
multiple interactions |
ISO |
6 |
125,271,358 |
125,294,961 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1 beta |
|
multiple interactions |
ISO |
7 |
129,008,625 |
129,062,030 |
RGD:6480464 |
CTD |
| G |
Scnn1g |
sodium channel, nonvoltage-gated 1 gamma |
|
multiple interactions |
ISO |
7 |
128,878,021 |
128,911,991 |
RGD:6480464 |
CTD |
| G |
Scnn1g |
sodium channel, nonvoltage-gated 1 gamma |
|
affects expression |
ISO |
7 |
128,878,021 |
128,911,991 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12, member 1 |
|
increases expression |
ISO |
2 |
124,978,336 |
125,055,738 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12, member 1 |
|
increases expression |
ISO |
2 |
124,978,336 |
125,055,738 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12, member 1 |
|
increases expression |
ISO |
2 |
124,978,336 |
125,055,738 |
RGD:6480464 |
CTD |
| G |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
|
multiple interactions |
ISO |
11 |
78,210,778 |
78,235,687 |
RGD:6480464 |
CTD |
| G |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
|
multiple interactions |
EXP |
11 |
78,210,778 |
78,235,687 |
RGD:6480464 |
CTD |
| G |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
|
multiple interactions |
ISO |
11 |
78,210,778 |
78,235,687 |
RGD:6480464 |
CTD |
| G |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
|
increases expression |
EXP |
7 |
58,877,200 |
58,926,496 |
RGD:6480464 |
CTD |
| G |
Slc17a7 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 |
|
increases expression |
EXP |
7 |
52,419,291 |
52,431,509 |
RGD:6480464 |
CTD |
| G |
Slc9a1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
|
multiple interactions |
ISO |
4 |
132,925,687 |
132,979,613 |
RGD:6480464 |
CTD |
| G |
Slc9a1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
|
increases activity |
EXP |
4 |
132,925,687 |
132,979,613 |
RGD:6480464 |
CTD |
| G |
Slc9a1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
|
decreases expression |
EXP |
4 |
132,925,687 |
132,979,613 |
RGD:6480464 |
CTD |
| G |
Slc9a3 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
|
increases expression |
ISO |
13 |
74,258,963 |
74,303,512 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
decreases expression |
ISO |
6 |
141,753,961 |
141,804,692 |
RGD:6480464 |
CTD |
| G |
Slit2 |
slit homolog 2 (Drosophila) |
|
increases expression |
ISO |
5 |
48,374,394 |
48,697,017 |
RGD:6480464 |
CTD |
| G |
Slit2 |
slit homolog 2 (Drosophila) |
|
decreases expression |
ISO |
5 |
48,374,394 |
48,697,017 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sparcl1 |
SPARC-like 1 |
|
affects localization |
ISO |
5 |
104,508,127 |
104,543,107 |
RGD:6480464 |
CTD |
| G |
Spc25 |
SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression |
ISO |
2 |
69,031,953 |
69,044,214 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
multiple interactions |
ISO |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Srcin1 |
SRC kinase signaling inhibitor 1 |
|
increases expression |
ISO |
11 |
97,370,654 |
97,436,440 |
RGD:6480464 |
CTD |
| G |
Stc2 |
stanniocalcin 2 |
|
decreases expression |
ISO |
11 |
31,259,441 |
31,270,061 |
RGD:6480464 |
CTD |
| G |
Stip1 |
stress-induced phosphoprotein 1 |
|
increases expression |
ISO |
19 |
7,095,186 |
7,114,516 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family 1A, phenol-preferring, member 1 |
|
decreases expression |
ISO |
7 |
133,816,384 |
133,819,871 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin 1 |
|
multiple interactions |
ISO |
6 |
7,505,071 |
7,512,973 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
7 |
150,078,681 |
150,085,871 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
decreases expression |
ISO |
7 |
72,441,051 |
72,516,130 |
RGD:6480464 |
CTD |
| G |
Tkt |
transketolase |
|
increases expression |
ISO |
14 |
31,362,335 |
31,387,908 |
RGD:6480464 |
CTD |
| G |
Tmx4 |
thioredoxin-related transmembrane protein 4 |
|
increases expression |
ISO |
2 |
134,420,237 |
134,469,857 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
ISO |
11 |
98,854,261 |
98,885,503 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
increases expression |
ISO |
6 |
124,760,610 |
124,764,314 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
decreases expression |
ISO |
9 |
66,870,400 |
66,897,020 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases transport |
EXP |
9 |
8,544,142 |
8,680,741 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
multiple interactions |
ISO |
10 |
77,370,467 |
77,432,617 |
RGD:6480464 |
CTD |
| G |
Ttk |
Ttk protein kinase |
|
increases expression |
ISO |
9 |
83,728,296 |
83,765,997 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
increases expression |
ISO |
2 |
164,595,429 |
164,598,402 |
RGD:6480464 |
CTD |
| G |
Uck1 |
uridine-cytidine kinase 1 |
|
increases expression |
ISO |
2 |
32,110,522 |
32,115,625 |
RGD:6480464 |
CTD |
| G |
Uhrf1 |
ubiquitin-like, containing PHD and RING finger domains, 1 |
|
increases expression |
ISO |
17 |
56,442,760 |
56,462,909 |
RGD:6480464 |
CTD |
| G |
Uqcrfs1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
|
increases expression |
ISO |
13 |
30,632,181 |
30,637,185 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vps29 |
vacuolar protein sorting 29 (S. pombe) |
|
increases expression |
ISO |
5 |
122,804,422 |
122,813,296 |
RGD:6480464 |
CTD |
| G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
|
increases expression |
ISO |
11 |
75,546,389 |
75,579,343 |
RGD:6480464 |
CTD |
| G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
|
decreases expression |
ISO |
12 |
21,396,190 |
21,423,297 |
RGD:6480464 |
CTD |
lithium carbonate
|
| G |
Alad |
aminolevulinate, delta-, dehydratase |
|
multiple interactions |
ISO |
4 |
62,170,204 |
62,181,097 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate, delta-, dehydratase |
|
decreases activity |
ISO |
4 |
62,170,204 |
62,181,097 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases expression |
EXP |
1 |
151,676,752 |
151,808,414 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
7 |
120,529,090 |
120,532,087 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases expression |
ISO |
7 |
120,529,090 |
120,532,087 |
RGD:6480464 |
CTD |
lithium chloride
|
| G |
Abat |
4-aminobutyrate aminotransferase |
|
decreases expression |
ISO |
16 |
8,513,522 |
8,621,661 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
EXP |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase family 1, subfamily A3 |
|
decreases expression |
ISO |
7 |
73,535,778 |
73,572,363 |
RGD:6480464 |
CTD |
| G |
Alppl2 |
alkaline phosphatase, placental-like 2 |
|
increases activity |
ISO |
1 |
88,983,265 |
88,986,503 |
RGD:6480464 |
CTD |
| G |
Amy1 |
amylase 1, salivary |
|
multiple interactions |
ISO |
3 |
113,258,870 |
113,280,668 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
decreases expression |
EXP |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
multiple interactions |
EXP |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 |
|
decreases expression |
ISO |
15 |
99,409,487 |
99,414,976 |
RGD:6480464 |
CTD |
| G |
Arf6 |
ADP-ribosylation factor 6 |
|
increases expression |
ISO |
12 |
70,473,137 |
70,476,967 |
RGD:6480464 |
CTD |
| G |
Arhgap29 |
Rho GTPase activating protein 29 |
|
increases expression |
ISO |
3 |
121,656,244 |
121,719,072 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 |
|
increases expression |
ISO |
15 |
80,085,614 |
80,087,971 |
RGD:6480464 |
CTD |
| G |
Atp5k |
ATP synthase, H+ transporting, mitochondrial F1F0 complex, subunit e |
|
decreases expression |
ISO |
5 |
108,862,272 |
108,863,397 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases expression |
ISO |
2 |
130,406,413 |
130,408,277 |
RGD:6480464 |
CTD |
| G |
Axin2 |
axin2 |
|
multiple interactions |
EXP |
11 |
108,781,663 |
108,812,097 |
RGD:6480464 |
CTD |
| G |
Axin2 |
axin2 |
|
increases expression |
ISO |
11 |
108,781,663 |
108,812,097 |
RGD:6480464 |
CTD |
| G |
Axin2 |
axin2 |
|
increases expression |
EXP |
11 |
108,781,663 |
108,812,097 |
RGD:6480464 |
CTD |
| G |
Bai3 |
brain-specific angiogenesis inhibitor 3 |
|
increases expression |
ISO |
1 |
25,124,321 |
25,886,552 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
increases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
increases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
increases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bglap2 |
bone gamma-carboxyglutamate protein 2 |
|
decreases expression |
EXP |
3 |
88,181,658 |
88,182,621 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
increases expression |
ISO |
14 |
47,003,195 |
47,010,274 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
increases expression |
ISO |
3 |
54,849,391 |
54,858,977 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
3 |
36,463,787 |
36,470,918 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
multiple interactions |
EXP |
3 |
36,463,787 |
36,470,918 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
ISO |
9 |
70,255,496 |
70,269,361 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
ISO |
9 |
70,255,496 |
70,269,361 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
affects localization |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases phosphorylation |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
decreases expression |
ISO |
4 |
11,118,501 |
11,131,926 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
increases expression |
ISO |
4 |
11,118,501 |
11,131,926 |
RGD:6480464 |
CTD |
| G |
Ccng2 |
cyclin G2 |
|
decreases expression |
ISO |
5 |
93,696,599 |
93,705,257 |
RGD:6480464 |
CTD |
| G |
Ccng2 |
cyclin G2 |
|
increases expression |
ISO |
5 |
93,696,599 |
93,705,257 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 antigen |
|
increases expression |
ISO |
2 |
164,881,136 |
164,897,154 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 antigen |
|
multiple interactions |
ISO |
2 |
164,881,136 |
164,897,154 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
decreases expression |
ISO |
18 |
34,892,651 |
34,911,187 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
increases expression |
ISO |
18 |
34,892,651 |
34,911,187 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
decreases expression |
ISO |
11 |
98,769,203 |
98,785,256 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
increases expression |
ISO |
11 |
98,769,203 |
98,785,256 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
multiple interactions |
ISO |
8 |
105,156,895 |
105,309,011 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
decreases expression |
ISO |
1 |
191,464,485 |
191,511,965 |
RGD:6480464 |
CTD |
| G |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing, zinc-binding protein 1 |
|
increases expression |
ISO |
9 |
18,096,711 |
18,118,444 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
increases expression |
EXP |
7 |
19,996,443 |
20,006,932 |
RGD:6480464 |
CTD |
| G |
Clk2 |
CDC-like kinase 2 |
|
decreases expression |
ISO |
3 |
88,968,727 |
88,981,009 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases expression |
ISO |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Crisp2 |
cysteine-rich secretory protein 2 |
|
decreases expression |
ISO |
17 |
40,901,686 |
40,931,039 |
RGD:6480464 |
CTD |
| G |
Ctcf |
CCCTC-binding factor |
|
increases expression |
ISO |
8 |
108,160,438 |
108,206,822 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases phosphorylation |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
EXP |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases activity |
EXP |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
EXP |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
EXP |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases localization |
EXP |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases activity |
EXP |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
affects localization |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases activity |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
EXP |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Efna3 |
ephrin A3 |
|
decreases expression |
ISO |
3 |
89,118,873 |
89,126,801 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Epha5 |
Eph receptor A5 |
|
decreases expression |
ISO |
5 |
84,483,786 |
84,846,407 |
RGD:6480464 |
CTD |
| G |
Epha5 |
Eph receptor A5 |
|
decreases expression |
ISO |
5 |
84,483,786 |
84,846,407 |
RGD:6480464 |
CTD |
| G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
increases expression |
ISO |
7 |
19,930,420 |
19,941,873 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III |
|
multiple interactions |
ISO |
3 |
121,426,455 |
121,437,970 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III |
|
decreases expression |
ISO |
3 |
121,426,455 |
121,437,970 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
decreases expression |
EXP |
15 |
58,011,634 |
58,046,433 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fyn |
Fyn proto-oncogene |
|
multiple interactions |
EXP |
10 |
39,089,605 |
39,285,187 |
RGD:6480464 |
CTD |
| G |
Fzd4 |
frizzled homolog 4 (Drosophila) |
|
increases expression |
ISO |
7 |
96,552,876 |
96,558,620 |
RGD:6480464 |
CTD |
| G |
Fzd6 |
frizzled homolog 6 (Drosophila) |
|
increases expression |
ISO |
15 |
38,837,826 |
38,869,738 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
multiple interactions |
EXP |
X |
7,536,386 |
7,544,941 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
multiple interactions |
EXP |
2 |
62,312,587 |
62,321,710 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
increases expression |
EXP |
2 |
62,312,587 |
62,321,710 |
RGD:6480464 |
CTD |
| G |
Gip |
gastric inhibitory polypeptide |
|
multiple interactions |
EXP |
11 |
95,885,859 |
95,892,142 |
RGD:6480464 |
CTD |
| G |
Gip |
gastric inhibitory polypeptide |
|
increases expression |
EXP |
11 |
95,885,859 |
95,892,142 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
affects localization |
ISO |
10 |
56,097,106 |
56,110,225 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
ISO |
10 |
56,097,106 |
56,110,225 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
ISO |
10 |
56,097,106 |
56,110,225 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
multiple interactions |
EXP |
2 |
25,146,697 |
25,174,683 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
decreases expression |
EXP |
2 |
25,146,697 |
25,174,683 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases expression |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
affects phosphorylation |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases stability |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
EXP |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
16 |
38,089,087 |
38,246,165 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase, mu 3 |
|
multiple interactions |
EXP |
3 |
107,766,614 |
107,772,076 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
EXP |
4 |
129,193,348 |
129,219,890 |
RGD:6480464 |
CTD |
| G |
Hdgfrp3 |
hepatoma-derived growth factor, related protein 3 |
|
decreases expression |
ISO |
7 |
89,026,142 |
89,079,345 |
RGD:6480464 |
CTD |
| G |
Hist1h1c |
histone cluster 1, H1c |
|
decreases expression |
ISO |
13 |
23,830,676 |
23,832,236 |
RGD:6480464 |
CTD |
| G |
Hist1h2bl |
histone cluster 1, H2bl |
|
decreases expression |
ISO |
13 |
21,807,632 |
21,808,012 |
RGD:6480464 |
CTD |
| G |
Hist1h4d |
histone cluster 1, H4d |
|
decreases expression |
ISO |
13 |
23,673,471 |
23,673,782 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Ibsp |
integrin binding sialoprotein |
|
decreases expression |
EXP |
5 |
104,728,306 |
104,740,491 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
decreases expression |
ISO |
4 |
135,699,737 |
135,701,307 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
EXP |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
EXP |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Itgb8 |
integrin beta 8 |
|
increases expression |
ISO |
12 |
120,401,276 |
120,476,749 |
RGD:6480464 |
CTD |
| G |
Krt34 |
keratin 34 |
|
increases expression |
ISO |
11 |
99,898,665 |
99,902,868 |
RGD:6480464 |
CTD |
| G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
multiple interactions |
EXP |
3 |
130,813,389 |
130,926,252 |
RGD:6480464 |
CTD |
| G |
Lig4 |
ligase IV, DNA, ATP-dependent |
|
increases expression |
ISO |
8 |
9,970,020 |
9,976,323 |
RGD:6480464 |
CTD |
| G |
Lrp6 |
low density lipoprotein receptor-related protein 6 |
|
increases expression |
ISO |
6 |
134,400,434 |
134,516,931 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
affects phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
affects phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
ISO |
11 |
104,092,750 |
104,193,410 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
increases expression |
ISO |
3 |
95,462,643 |
95,467,102 |
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance deficient 2 mitotin (S. cerevisiae) |
|
decreases expression |
ISO |
6 |
88,833,468 |
88,848,774 |
RGD:6480464 |
CTD |
| G |
Mcm4 |
minichromosome maintenance deficient 4 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
16 |
15,623,990 |
15,637,493 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance deficient 5, cell division cycle 46 (S. cerevisiae) |
|
decreases expression |
ISO |
8 |
77,633,427 |
77,652,338 |
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance deficient 6 (MIS5 homolog, S. pombe) (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
130,228,168 |
130,256,233 |
RGD:6480464 |
CTD |
| G |
Mcm7 |
minichromosome maintenance deficient 7 (S. cerevisiae) |
|
decreases expression |
ISO |
5 |
138,605,817 |
138,613,090 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
|
multiple interactions |
EXP |
7 |
142,881,471 |
142,908,062 |
RGD:6480464 |
CTD |
| G |
Mrpl47 |
mitochondrial ribosomal protein L47 |
|
decreases expression |
ISO |
3 |
32,626,419 |
32,635,677 |
RGD:6480464 |
CTD |
| G |
Msi1 |
musashi RNA-binding protein 1 |
|
increases expression |
ISO |
5 |
115,879,694 |
115,904,211 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myh4 |
myosin, heavy polypeptide 4, skeletal muscle |
|
multiple interactions |
EXP |
11 |
67,051,531 |
67,073,948 |
RGD:6480464 |
CTD |
| G |
Myh4 |
myosin, heavy polypeptide 4, skeletal muscle |
|
increases expression |
EXP |
11 |
67,051,531 |
67,073,948 |
RGD:6480464 |
CTD |
| G |
Myh8 |
myosin, heavy polypeptide 8, skeletal muscle, perinatal |
|
increases expression |
EXP |
11 |
67,090,626 |
67,122,136 |
RGD:6480464 |
CTD |
| G |
Nanog |
Nanog homeobox |
|
increases expression |
ISO |
6 |
122,657,586 |
122,663,796 |
RGD:6480464 |
CTD |
| G |
Nanog |
Nanog homeobox |
|
multiple interactions |
ISO |
6 |
122,657,586 |
122,663,796 |
RGD:6480464 |
CTD |
| G |
Nfatc3 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 |
|
increases activity |
EXP |
8 |
108,583,503 |
108,654,437 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
ISO |
5 |
118,317,128 |
118,403,822 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
decreases expression |
ISO |
10 |
3,308,332 |
3,557,940 |
RGD:6480464 |
CTD |
| G |
Pax3 |
paired box gene 3 |
|
increases expression |
ISO |
1 |
78,097,842 |
78,193,711 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pdlim5 |
PDZ and LIM domain 5 |
|
increases expression |
ISO |
3 |
141,903,568 |
142,058,630 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol 3-kinase, catalytic, alpha polypeptide |
|
multiple interactions |
ISO |
3 |
32,335,073 |
32,367,408 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol 3-kinase, catalytic, alpha polypeptide |
|
affects response to substance |
ISO |
3 |
32,335,073 |
32,367,408 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol 3-kinase, catalytic, alpha polypeptide |
|
increases response to substance |
ISO |
3 |
32,335,073 |
32,367,408 |
RGD:6480464 |
CTD |
| G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
|
increases expression |
ISO |
5 |
111,759,783 |
111,817,379 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
decreases expression |
ISO |
14 |
21,655,884 |
21,662,610 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
66,618,258 |
66,625,212 |
RGD:6480464 |
CTD |
| G |
Popdc3 |
popeye domain containing 3 |
|
increases expression |
ISO |
10 |
45,009,111 |
45,038,256 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
multiple interactions |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
increases expression |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
increases expression |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
multiple interactions |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
increases expression |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) |
|
increases expression |
ISO |
11 |
17,059,301 |
17,100,383 |
RGD:6480464 |
CTD |
| G |
Prr16 |
proline rich 16 |
|
decreases expression |
ISO |
18 |
51,277,552 |
51,464,295 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
increases expression |
EXP |
2 |
30,744,991 |
30,758,817 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
multiple interactions |
EXP |
2 |
30,744,991 |
30,758,817 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Rab23 |
RAB23, member RAS oncogene family |
|
increases expression |
ISO |
1 |
33,776,741 |
33,799,409 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
EXP |
14 |
73,595,309 |
73,725,598 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
14 |
73,595,309 |
73,725,598 |
RGD:6480464 |
CTD |
| G |
Rcan1 |
regulator of calcineurin 1 |
|
increases expression |
ISO |
16 |
92,392,198 |
92,466,391 |
RGD:6480464 |
CTD |
| G |
Rgs4 |
regulator of G-protein signaling 4 |
|
increases expression |
ISO |
1 |
171,671,608 |
171,677,773 |
RGD:6480464 |
CTD |
| G |
Rnd3 |
Rho family GTPase 3 |
|
increases expression |
ISO |
2 |
50,985,959 |
51,004,631 |
RGD:6480464 |
CTD |
| G |
Rrad |
Ras-related associated with diabetes |
|
increases expression |
ISO |
8 |
107,151,966 |
107,155,221 |
RGD:6480464 |
CTD |
| G |
Scn5a |
sodium channel, voltage-gated, type V, alpha |
|
decreases activity |
ISO |
9 |
119,392,529 |
119,488,134 |
RGD:6480464 |
CTD |
| G |
Sfrp2 |
secreted frizzled-related protein 2 |
|
decreases expression |
ISO |
3 |
83,570,243 |
83,578,236 |
RGD:6480464 |
CTD |
| G |
Sfrp2 |
secreted frizzled-related protein 2 |
|
multiple interactions |
ISO |
3 |
83,570,243 |
83,578,236 |
RGD:6480464 |
CTD |
| G |
Six1 |
sine oculis-related homeobox 1 |
|
increases expression |
ISO |
12 |
74,142,814 |
74,147,699 |
RGD:6480464 |
CTD |
| G |
Six1 |
sine oculis-related homeobox 1 |
|
increases response to substance |
ISO |
12 |
74,142,814 |
74,147,699 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12, member 1 |
|
decreases expression |
EXP |
2 |
124,978,336 |
125,055,738 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12, member 1 |
|
multiple interactions |
EXP |
2 |
124,978,336 |
125,055,738 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20, member 1 |
|
increases expression |
ISO |
2 |
129,024,509 |
129,037,351 |
RGD:6480464 |
CTD |
| G |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression |
ISO |
19 |
8,781,372 |
8,797,859 |
RGD:6480464 |
CTD |
| G |
Slc5a3 |
solute carrier family 5 (inositol transporters), member 3 |
|
increases expression |
ISO |
16 |
92,058,567 |
92,087,718 |
RGD:6480464 |
CTD |
| G |
Snai1 |
snail homolog 1 (Drosophila) |
|
decreases degradation |
ISO |
2 |
167,363,727 |
167,368,314 |
RGD:6480464 |
CTD |
| G |
Snai1 |
snail homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
2 |
167,363,727 |
167,368,314 |
RGD:6480464 |
CTD |
| G |
Snai1 |
snail homolog 1 (Drosophila) |
|
multiple interactions |
EXP |
2 |
167,363,727 |
167,368,314 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
multiple interactions |
EXP |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Stard7 |
START domain containing 7 |
|
multiple interactions |
ISO |
2 |
127,095,965 |
127,124,670 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 |
|
multiple interactions |
ISO |
11 |
100,748,124 |
100,800,825 |
RGD:6480464 |
CTD |
| G |
Tars |
threonyl-tRNA synthetase |
|
increases expression |
ISO |
15 |
11,313,418 |
11,329,413 |
RGD:6480464 |
CTD |
| G |
Tbc1d8 |
TBC1 domain family, member 8 |
|
decreases expression |
ISO |
1 |
39,428,340 |
39,535,592 |
RGD:6480464 |
CTD |
| G |
Tcf4 |
transcription factor 4 |
|
multiple interactions |
ISO |
18 |
69,504,146 |
69,847,621 |
RGD:6480464 |
CTD |
| G |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
|
increases expression |
ISO |
3 |
57,090,986 |
57,105,841 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tph2 |
tryptophan hydroxylase 2 |
|
decreases expression |
ISO |
10 |
114,515,697 |
114,622,078 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
decreases expression |
ISO |
4 |
59,202,422 |
59,235,705 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
increases expression |
ISO |
2 |
13,495,938 |
13,504,453 |
RGD:6480464 |
CTD |
| G |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
increases expression |
ISO |
13 |
89,988,519 |
90,229,213 |
RGD:6480464 |
CTD |
| G |
Yes1 |
Yamaguchi sarcoma viral (v-yes) oncogene homolog 1 |
|
multiple interactions |
EXP |
5 |
32,913,606 |
32,989,430 |
RGD:6480464 |
CTD |
| G |
Zfp207 |
zinc finger protein 207 |
|
increases expression |
ISO |
11 |
80,216,149 |
80,240,529 |
RGD:6480464 |
CTD |
| G |
Zmynd8 |
zinc finger, MYND-type containing 8 |
|
decreases expression |
ISO |
2 |
165,609,654 |
165,710,188 |
RGD:6480464 |
CTD |
Term paths to the root
|